AIM: TYR
TyraTech was formed in 2004 to develop and commercialize products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally.
" 2009 has been a year of development and we now have a solid platform for future growth and revenue
generation. We are confident of our ability to take this technology to market with products that our partners can
commercialise. Furthermore, we are committed to leveraging these products into their markets in the US and globally:
creating significant shareholder value over the coming years."
Alan Reade, Executive Chairman
